Quipt Home Medical Corp. (NASDAQ:QIPT) Short Interest Update

Quipt Home Medical Corp. (NASDAQ:QIPT) was the target of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 1,430,000 shares, a growth of 36.2% from the December 15th total of 1,050,000 shares. Based on an average daily volume of 191,800 shares, the days-to-cover ratio is currently 7.5 days. Approximately 3.7% of the shares of the company are sold short.

Quipt Home Medical Stock Performance

NASDAQ:QIPT traded down $0.01 during mid-day trading on Thursday, hitting $2.97. 32,021 shares of the stock were exchanged, compared to its average volume of 177,169. Quipt Home Medical has a fifty-two week low of $2.30 and a fifty-two week high of $4.99. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.86 and a current ratio of 1.20. The firm’s 50-day simple moving average is $2.71 and its 200 day simple moving average is $2.89. The stock has a market capitalization of $127.98 million, a price-to-earnings ratio of -19.80 and a beta of 0.56.

Quipt Home Medical (NASDAQ:QIPT) last posted its quarterly earnings data on Monday, December 16th. The company reported ($0.07) EPS for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.08). Quipt Home Medical had a negative return on equity of 6.18% and a negative net margin of 2.66%. As a group, equities analysts anticipate that Quipt Home Medical will post -0.15 EPS for the current fiscal year.

Insider Buying and Selling at Quipt Home Medical

In other news, VP Patrick Dennis Gamble acquired 17,000 shares of Quipt Home Medical stock in a transaction dated Thursday, December 26th. The stock was bought at an average price of $2.45 per share, for a total transaction of $41,650.00. Following the completion of the acquisition, the vice president now directly owns 40,057 shares in the company, valued at approximately $98,139.65. The trade was a 73.73 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 4.20% of the company’s stock.

Institutional Investors Weigh In On Quipt Home Medical

A number of hedge funds have recently made changes to their positions in the stock. ProShare Advisors LLC bought a new stake in shares of Quipt Home Medical in the second quarter worth $35,000. SG Americas Securities LLC purchased a new stake in shares of Quipt Home Medical in the third quarter worth approximately $44,000. Atom Investors LP bought a new position in shares of Quipt Home Medical during the 3rd quarter valued at approximately $51,000. XTX Topco Ltd purchased a new stake in Quipt Home Medical during the 3rd quarter worth about $54,000. Finally, JPMorgan Chase & Co. boosted its holdings in Quipt Home Medical by 68.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 30,403 shares of the company’s stock valued at $89,000 after purchasing an additional 12,383 shares during the period. 42.85% of the stock is currently owned by institutional investors and hedge funds.

About Quipt Home Medical

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.